Impact of previous aspergillosis on the outcome of bone marrow transplantation

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1098-1103

  Offner, F ^a   Cordonnier, C ^b   Ljungman, P ^b   Prentice, H G ^b   Engelhard, D ^b   De Bacquer, D ^b   Meunier, F ^b   De Pauw, B ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; BUSULFAN; COLONY STIMULATING FACTOR 1; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; METHOTREXATE; STEROID; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLOSIS; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LUNG LOBECTOMY; LYMPHOCYTE DEPLETION; MALE; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; T LYMPHOCYTE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0031950358     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520274     Document Type: Article

References (18)

1. Bodey G, Bueltmann B, Duguid W, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992;11:99-109.
2. Jandrlic M, Kalenic S, Labar B, et al. An autopsy study of systemic fungal infections in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1995;14:768-73.
3. Walsh TJ, Hiemenz J, Pizzo PA. Editorial response: evolving risk factors for invasive fungal infections - all neutropenic patients are not the same. Clin Infect Dis 1994;18:793-8.
4. D'Antonio D, Iacone A, Schioppa FS, Bonginii T, Romano F. Effect of the current antimicrobial strategy on fungal colonization in patients with hematological malignancies. Curr Microbiol 1996;33:118-22.
5. Guiot HFL, Fibbe WE, van't Wout JW. Risk factors for fungal infections in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994;18:525-32.
6. Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer 1984;53:411-9.
7. Willemze R, Zijlmans DM, den Ottolander J, Kluin-Nelemans C. High dose Ara-C for remission induction and consolidation of previously untreated adults with ALL. Ann Hematol 1995;70:71-4.
8. Bow EJ, Loewen R, Cheang MS, Schacter B. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin Infect Dis 1995;21:361-9.
9. Denning DN, Marinus A, Cohen J, et al. Risk factors and outcome from invasive aspergillosis (IA) [abstract no J49]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1996:227.
10. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990;12:147-220.
11. Goodrich JM, Reed EC, Mari M, et al. Clinical features and analysis of risk factors for invasive candidal infections after marrow transplantation. J Infect Dis 1991;164:731-40.
12. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992;326:845-51.
13. Morrison VA, Haake RJ, Weisdorf DJ. Non-candida fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med 1994;96:497-503.
14. Cordonnier C, Beaune J, Offner F, Marinus A, Ljungman P, Meunier F. Aspergillosis prior to BMT. Bone Marrow Transplant 1995;16:323-4.
15. Robinson LA, Reed EC, Galbraith TA, Alonso A, Moulton AL, Fleming WH. Pulmonary resection for invasive aspergillus infections in immunocompromised hosts. J Thorac Cardiovasc Surg 1995;109:1182-96.
16. Lupinetti PM, Behrendt DM, Giller RH, Trigg ME, de Alarcon P. Pulmonary resection for fungal infection in children undergoing bone marrow transplantation. J Thorac Cardiovasc Surg 1992;104:684-7.
17. O'Donell MR, Schmidt GM, Tegmeier BR, et al. Prediction of systemic fungal infection in allogenic marrow graft recipients: impact of amphotericin B prophylaxis in high risk patients. J Clin Oncol 1994;12:827-34.
18. Offner F. Hematopoietic growth factors in cancer patients with invasive fungal infections. Eur J Clin Microbiol Infect Dis 1997;16:56-63.